TY - JOUR
T1 - Physical Activity and Colorectal Cancer Prognosis According to Tumor-Infiltrating T Cells
AU - Koh, Hideo
AU - Hamada, Tsuyoshi
AU - Song, Mingyang
AU - Liu, Li
AU - Cao, Yin
AU - Nowak, Jonathan A.
AU - da Silva, Annacarolina
AU - Twombly, Tyler
AU - Morikawa, Teppei
AU - Kim, Sun A.
AU - Masugi, Yohei
AU - Kosumi, Keisuke
AU - Shi, Yan
AU - Gu, Mancang
AU - Li, Wanwan
AU - Du, Chunxia
AU - Chen, Yang
AU - Li, Wenbin
AU - Liu, Hongli
AU - Li, Chenxi
AU - Wu, Kana
AU - Nosho, Katsuhiko
AU - Inamura, Kentaro
AU - Hanyuda, Akiko
AU - Zhang, Xuehong
AU - Giannakis, Marios
AU - Chan, Andrew T.
AU - Fuchs, Charles S.
AU - Nishihara, Reiko
AU - Meyerhardt, Jeffrey A.
AU - Ogino, Shuji
N1 - Funding Information:
This work was supported by US National Institutes of Health (NIH) grants (P01 CA87969 to MJ Stampfer; UM1 CA186107 to MJ Stampfer; P01 CA55075 to WC Willett; UM1 CA167552 to WC Willett; U01 CA167552 to WC Willett and LA Mucci; P50 CA127003 to CSF; R01 CA118553 to CSF; R01 CA169141 to CSF; R01 CA137178 to ATC; K24 DK098311 to ATC; R35 CA197735 to SO; R01 CA151993 to SO; K07 CA190673 to RN; and K07 CA188126 to XZ); by Nodal Award (2016-02) from Dana-Farber Cancer Institute (SO); by the Stand Up To Cancer Colorectal Cancer Dream Team Translational Research Grant (grant number SU2C-AACR-DT22-17 administered by the American Association for Cancer Research, scientific partner of SU2C to MGi and CSF); and by grants from the Project P Fund, The Friends of the Dana-Farber Cancer Institute, Bennett Family Fund, and the Entertainment Industry Foundation through National Colorectal Cancer Research Alliance. LL was supported by a scholarship grant from Chinese Scholarship Council and a fellowship grant from Huazhong University of Science and Technology. KK was supported by grants from Overseas Research Fellowship (JP2017-775). ATC is a Stuart and Suzanne Steele MGH Research Scholar. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Publisher Copyright:
© The Author(s) 2019.
PY - 2018/10/1
Y1 - 2018/10/1
N2 - Background: Evidence suggests that high-level physical activity may potentially reduce cancer mortality through its immune enhancement effect. We therefore hypothesized that survival benefits associated with physical activity might be stronger in colorectal carcinomas with lower immune reaction at diagnosis. Methods: Using molecular pathological epidemiology databases of 470 colon and rectal carcinoma cases in the Nurses’ Health Study and the Health Professionals Follow-up Study, we assessed the prognostic association of postdiagnosis physical activity in strata of densities of CD3þ cells, CD8þ cells, CD45RO (PTPRC)þ cells, or FOXP3þ cells in tumor tissue. Cox proportional hazards regression model was used to adjust for potential confounders, including microsatellite instability, CpG island methylator phenotype, long interspersed nucleotide element-1 methylation, KRAS, BRAF, and PIK3CA mutations, and expression of CTNNB1 (beta-catenin), PTGS2 (cyclooxygenase-2), and IRS1. Results: The association of postdiagnosis physical activity with colorectal cancer-specific mortality differed by CD3þ cell density (Pinteraction < .001). Multivariable-adjusted colorectal cancer-specific mortality hazard ratios for a quartile-unit increase in physical activity were 0.56 (95% confidence interval = 0.38 to 0.83) among cases with the lowest quartile of CD3þ cell density compared with 1.14 (95% confidence interval = 0.79 to 1.65) in cases with the highest quartile. We observed no differential survival association of physical activity by densities of CD8þ cells, CD45ROþ cells, or FOXP3þ cells. Conclusions: The association between postdiagnosis physical activity and colorectal cancer survival appeared stronger for carcinomas with lower T cell infiltrates, suggesting an interactive effect of exercise and immunity on colorectal cancer progression.
AB - Background: Evidence suggests that high-level physical activity may potentially reduce cancer mortality through its immune enhancement effect. We therefore hypothesized that survival benefits associated with physical activity might be stronger in colorectal carcinomas with lower immune reaction at diagnosis. Methods: Using molecular pathological epidemiology databases of 470 colon and rectal carcinoma cases in the Nurses’ Health Study and the Health Professionals Follow-up Study, we assessed the prognostic association of postdiagnosis physical activity in strata of densities of CD3þ cells, CD8þ cells, CD45RO (PTPRC)þ cells, or FOXP3þ cells in tumor tissue. Cox proportional hazards regression model was used to adjust for potential confounders, including microsatellite instability, CpG island methylator phenotype, long interspersed nucleotide element-1 methylation, KRAS, BRAF, and PIK3CA mutations, and expression of CTNNB1 (beta-catenin), PTGS2 (cyclooxygenase-2), and IRS1. Results: The association of postdiagnosis physical activity with colorectal cancer-specific mortality differed by CD3þ cell density (Pinteraction < .001). Multivariable-adjusted colorectal cancer-specific mortality hazard ratios for a quartile-unit increase in physical activity were 0.56 (95% confidence interval = 0.38 to 0.83) among cases with the lowest quartile of CD3þ cell density compared with 1.14 (95% confidence interval = 0.79 to 1.65) in cases with the highest quartile. We observed no differential survival association of physical activity by densities of CD8þ cells, CD45ROþ cells, or FOXP3þ cells. Conclusions: The association between postdiagnosis physical activity and colorectal cancer survival appeared stronger for carcinomas with lower T cell infiltrates, suggesting an interactive effect of exercise and immunity on colorectal cancer progression.
UR - http://www.scopus.com/inward/record.url?scp=85065929255&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85065929255&partnerID=8YFLogxK
U2 - 10.1093/JNCICS/PKY058
DO - 10.1093/JNCICS/PKY058
M3 - Article
C2 - 31276098
AN - SCOPUS:85065929255
SN - 2515-5091
VL - 2
JO - JNCI Cancer Spectrum
JF - JNCI Cancer Spectrum
IS - 4
M1 - pky058
ER -